News
- Author:
- Liam Davenport
Publish date: January 4, 2024
The authors “observed no evidence for added value of chemotherapy” for ER-positive, HER2-negative invasive lobular carcinoma who received endocrine...
News
- Author:
- Liam Davenport
Publish date: December 19, 2023
Patients with severe sickle cell disease aged 12 and older could benefit greatly from two newly approved gene-editing treatments.
News
- Author:
- Liam Davenport
Publish date: December 18, 2023
Older patients with advanced HER2+ breast cancer do not experience a survival benefit with trastuzumab emtansine vs standard-of-care combination th...
News
- Author:
- Liam Davenport
Publish date: December 18, 2023
In this animal study, the song induced the release of 70% of available insulin within 5 minutes and 100% within 15 minutes.
News
- Author:
- Liam Davenport
Publish date: December 14, 2023
Women with early breast cancer can safely undergo less extensive axillary surgery because it has no impact on recurrence or mortality rate.
News
- Author:
- Liam Davenport
Publish date: November 30, 2023
Exposure to anti-HER2 agents was associated with “severe specific adverse pregnancy and fetal or newborn outcomes compared with exposure to other a...
News
- Author:
- Liam Davenport
Publish date: November 29, 2023
“What we’re seeing is that more insulin is needed to normalize glucose levels in the women under conditions of sleep restriction.”
News
- Author:
- Liam Davenport
Publish date: November 16, 2023
Several diabetes educators have reported that humor can encourage and support diabetes management, said Dr. David Greene.
News
- Author:
- Liam Davenport
Publish date: October 27, 2023
The question of whether to give upfront immunochemotherapy in resectable non–small cell lung cancer, wait until after surgery, or give both remains...
News
- Author:
- Liam Davenport
Publish date: October 26, 2023
Data from three trials with amivantamab in advanced EGFR-mutant NSCLC have yielded “exciting” results with experts hailing the drug as standard of ...
News
- Author:
- Liam Davenport
Publish date: October 26, 2023
The study “makes me feel pretty comfortable that regardless of where you’re delivering the therapy, IV or subcutaneously, it’s getting in there and...
News
- Author:
- Liam Davenport
Publish date: October 26, 2023
Compared with the placebo group, participants taking escitalopram had a marked increase in synaptic density.
News
- Author:
- Liam Davenport
Publish date: October 25, 2023
Building a sustainable oncology workforce will not be easy, but improving staffing shortages and integrating resilience training can help, experts ...
News
- Author:
- Liam Davenport
Publish date: October 25, 2023
‘Frame running’ uses a three-wheeled frame with a saddle and body supports but no pedals to allow individuals with disabilities and balance impairm...
News
- Author:
- Liam Davenport
Publish date: October 25, 2023
Rezpegaldesleukin is now being evaluated in a phase 2b study for moderate to severe atopic dermatitis, and a phase 2b trial for alopecia areata is ...
